An updated forecast for META (Facebook) is now available in the Equity Forecast Section of the website. The updated forecast reflects two highly correlated exogenous data sets. Access the updated forecast here. To sign up to the EquiPredict Analytics free quarterly forecast, visit the sign up page HERE.
At EquiPredict Analytics, one of the core forecasting tools we utilize is exogenous data driver sets. These data “drivers” are external variables that tend to lead and influence price action — helping to anticipate market movements before they happen. When an EquiPredict Red Wave or Blue Wave forecast aligns with an exogenous data driver forecast,…
***This content is restricted to subscribers of EquiPredict Analytics. Please log-in to view all forecasts and reports.***
The June 2025 EquiPredict newsletter is now available and can be found HERE in the subscriber area. Each monthly newsletter contains concise data on where Wall Street is allocating their funds via sector strength, industry strength, and market commentary information. Interested in a free quarterly EquiPredict forecast? Sign up for that here.
***This content is restricted to subscribers of EquiPredict Analytics. Please log-in to view all forecasts and reports.***
The chart below features a forecast for Bristol Myers Squibb (NYSE: BMY), created using two of our proprietary models here at EquiPredict Analytics: Both models indicate a potential upward price trend for BMY stock, starting now and continuing into Fall 2025. This bullish forecast is based on historical cycles, technical indicators, and external data correlations….
***This content is restricted to subscribers of EquiPredict Analytics. Please log-in to view all forecasts and reports.***
***This content is restricted to subscribers of EquiPredict Analytics. Please log-in to view all forecasts and reports.***
***This content is restricted to subscribers of EquiPredict Analytics. Please log-in to view all forecasts and reports.***
***This content is restricted to subscribers of EquiPredict Analytics. Please log-in to view all forecasts and reports.***
